The evolutionary history of 2,658 cancers

Abstract

Cancer develops through a process of somatic evolution 1,2 . Sequencing data from a single biopsy represent a snapshot of this process that can reveal the timing of specific genomic aberrations and the changing influence of mutational processes 3 . Here, by whole-genome sequencing analysis of 2,658 cancers as part of the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium of the International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA) 4 , we reconstruct the life history and evolution of mutational processes and driver mutation sequences of 38 types of cancer. Early oncogenesis is characterized by mutations in a constrained set of driver genes, and specific copy number gains, such as trisomy 7 in glioblastoma and isochromosome 17q in medulloblastoma. The mutational spectrum changes significantly throughout tumour evolution in 40% of samples. A nearly fourfold diversification of driver genes and increased genomic instability are features of later stages. Copy number alterations often occur in mitotic crises, and lead to simultaneous gains of chromosomal segments. Timing analyses suggest that driver mutations often precede diagnosis by many years, if not decades. Together, these results determine the evolutionary trajectories of cancer, and highlight opportunities for early cancer detection.

References 47

1. 1.

   Cairns J. Mutation selection and the natural history of cancer. Nature. 1975;255:197-200.

   Not in our library10.1038/255197a0

2. 2.

   Martincorena I, Campbell PJ. Somatic mutation in cancer and normal cells. Science. 2015;349:1483-1489.

   Not in our library10.1126/science.aab4082

3. 3.
   The Life History of 21 Breast Cancers · 2012

   Corrected
4. 4.
   Pan-cancer analysis of whole genomes · 2020

   Corrected
5. 5.

   Moore, L. et al. The mutational landscape of normal human endometrial epithelium. Preprint at bioRxiv 10.1101/505685 (2018).

   Not in our library

6. 6.

   Lee-Six H, et al. The landscape of somatic mutation in normal colorectal epithelial cells. Nature. 2019;574:532-537.

   Not in our library10.1038/s41586-019-1672-7

7. 7.

   Lee-Six H, et al. Population dynamics of normal human blood inferred from somatic mutations. Nature. 2018;561:473-478.

   Not in our library10.1038/s41586-018-0497-0

8. 8.

   Martincorena I, et al. Somatic mutant clones colonize the human esophagus with age. Science. 2018;362:911-917.

   Not in our library10.1126/science.aau3879

9. 9.

   Martincorena I, et al. High burden and pervasive positive selection of somatic mutations in normal human skin. Science. 2015;348:880-886.

   Not in our library10.1126/science.aaa6806

10. 10.

    Welch JS, et al. The origin and evolution of mutations in acute myeloid leukemia. Cell. 2012;150:264-278.

    Not in our library10.1016/j.cell.2012.06.023

11. 11.

    Yokoyama A, et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature. 2019;565:312-317.

    Not in our library10.1038/s41586-018-0811-x

12. 12.

    Alexandrov LB, et al. Clock-like mutational processes in human somatic cells. Nat. Genet. 2015;47:1402-1407.

    Not in our library10.1038/ng.3441

13. 13.

    Nowell PC. The clonal evolution of tumor cell populations. Science. 1976;194:23-28.

    Not in our library10.1126/science.959840

14. 14.

    Durinck S, et al. Temporal dissection of tumorigenesis in primary cancers. Cancer Discov. 2011;1:137-143.

    Not in our library10.1158/2159-8290.cd-11-0028

15. 15.

    Jolly C, Van Loo P. Timing somatic events in the evolution of cancer. Genome Biol. 2018;19:95.

    Not in our library10.1186/s13059-018-1476-3

16. 16.
    Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal · 2018

    No notice
17. 17.

    Gerlinger M, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 2012;366:883-892.

    Not in our library10.1056/nejmoa1113205

18. 18.

    Gundem G, et al. The evolutionary history of lethal metastatic prostate cancer. Nature. 2015;520:353-357.

    Not in our library10.1038/nature14347

19. 19.

    Yates LR, et al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat. Med. 2015;21:751-759.

    Not in our library10.1038/nm.3886

20. 20.

    Brastianos PK, et al. Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets. Cancer Discov. 2015;5:1164-1177.

    Not in our library10.1158/2159-8290.cd-15-0369

21. 21.

    Papaemmanuil E, et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood. 2013;122:3616-3627.

    Not in our library10.1182/blood-2013-08-518886

22. 22.

    Landau DA, et al. Mutations driving CLL and their evolution in progression and relapse. Nature. 2015;526:525-530.

    Not in our library10.1038/nature15395

23. 23.

    Rheinbay, E. et al. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature10.1038/s41586-020-1965-x (2020).

    Not in our library10.1038/s41586-022-05599-9

24. 24.
    The repertoire of mutational signatures in human cancer · 2020

    Corrected
25. 25.

    Keogh MJ, et al. High prevalence of focal and multi-focal somatic genetic variants in the human brain. Nat. Commun. 2018;9:4257.

    Not in our library10.1038/s41467-018-06331-w

26. 26.

    Heim S, et al. Trisomy 7 and sex chromosome loss in human brain tissue. Cytogenet. Cell Genet. 1989;52:136-138.

    Not in our library10.1159/000132863

27. 27.

    Ganem NJ, Godinho SA, Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature. 2009;460:278-282.

    Not in our library10.1038/nature08136

28. 28.

    Sheltzer JM, et al. Single-chromosome gains commonly function as tumor suppressors. Cancer Cell. 2017;31:240-255.

    Not in our library10.1016/j.ccell.2016.12.004

29. 29.

    Gao R, et al. Punctuated copy number evolution and clonal stasis in triple-negative breast cancer. Nat. Genet. 2016;48:1119-1130.

    Not in our library10.1038/ng.3641

30. 30.

    Cross W, et al. The evolutionary landscape of colorectal tumorigenesis. Nat. Ecol. Evol. 2018;2:1661-1672.

    Not in our library10.1038/s41559-018-0642-z

31. 31.

    Gerlinger M, et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat. Genet. 2014;46:225-233.

    Not in our library10.1038/ng.2891

32. 32.

    Gibson WJ, et al. The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis. Nat. Genet. 2016;48:848-855.

    Not in our library10.1038/ng.3602

33. 33.
    Genomic Evolution of Breast Cancer Metastasis and Relapse · 2017

    No notice
34. 34.

    Jamal-Hanjani M, et al. Tracking the evolution of non-small-cell lung cancer. N. Engl. J. Med. 2017;376:2109-2121.

    Not in our library10.1056/nejmoa1616288

35. 35.

    Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759-767.

    Not in our library10.1016/0092-8674(90)90186-i

36. 36.

    Alexandrov LB, et al. Signatures of mutational processes in human cancer. Nature. 2013;500:415-421.

    Not in our library10.1038/nature12477

37. 37.

    McGranahan N, et al. Clonal status of actionable driver events and the timing of mutational processes in cancer evolution. Sci. Transl. Med. 2015;7:283ra54.

    Not in our library10.1126/scitranslmed.aaa1408

38. 38.
    deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution · 2016

    No notice
39. 39.

    Patch A-M, et al. Whole-genome characterization of chemoresistant ovarian cancer. Nature. 2015;521:489-494.

    Not in our library10.1038/nature14410

40. 40.

    Bostwick DG, Qian J. High-grade prostatic intraepithelial neoplasia. Mod. Pathol. 2004;17:360-379.

    Not in our library10.1038/modpathol.3800053

41. 41.

    Brenner H, et al. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut. 2007;56:1585-1589.

    Not in our library10.1136/gut.2007.122739

42. 42.

    Gazdar AF, Brambilla E. Preneoplasia of lung cancer. Cancer Biomark. 2010;9:385-396.

    Not in our library10.3233/cbm-2011-0166

43. 43.

    Sanders ME, Schuyler PA, Dupont WD, Page DL. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer. 2005;103:2481-2484.

    Not in our library10.1002/cncr.21069

44. 44.

    Schlecht NF, et al. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 2003;95:1336-1343.

    Not in our library10.1093/jnci/djg037

45. 45.

    Whitson MJ, Falk GW. Predictors of progression to high-grade dysplasia or adenocarcinoma in Barrett’s esophagus. Gastroenterol. Clin. North Am. 2015;44:299-315.

    Not in our library10.1016/j.gtc.2015.02.005

46. 46.

    Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat. Rev. Cancer. 2002;2:897-909.

    Not in our library10.1038/nrc949

47. 47.

    Folkins AK, et al. A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. Gynecol. Oncol. 2008;109:168-173.

    Not in our library10.1016/j.ygyno.2008.01.012

Cited by papers we hold 35

• Geographic and age variations in mutational processes in colorectal cancer · 2025
  No notice
• The genomic landscape of 2,023 colorectal cancers · 2024
  No notice
• Prognostic genome and transcriptome signatures in colorectal cancers · 2024
  No notice
• Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets · 2024
  No notice
• Evolutionary trajectories of small cell lung cancer under therapy · 2024
  No notice
• Pan-cancer whole-genome comparison of primary and metastatic solid tumours · 2023
  No notice
• The evolution of lung cancer and impact of subclonal selection in TRACERx · 2023
  Corrected
• Slide-tags enables single-nucleus barcoding for multimodal spatial genomics · 2023
  Corrected
• Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studies [version 4; peer review: 2 approved] · 2022
  Not checked
• Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of PLOD2 · 2022
  Not checked
• A phylogenetic approach to study the evolution of somatic mutational processes in cancer · 2022
  Not checked
• Spatial genomics maps the structure, nature and evolution of cancer clones · 2022
  No notice
• Ordered and deterministic cancer genome evolution after p53 loss · 2022
  No notice
• Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways · 2022
  Corrected
• Ovarian cancer mutational processes drive site-specific immune evasion · 2022
  No notice
• Detection of early seeding of Richter transformation in chronic lymphocytic leukemia · 2022
  No notice
• Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture · 2021
  Not checked
• Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden · 2021
  No notice
• Cancer evolution: Darwin and beyond · 2021
  No notice
• Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities · 2021
  No notice

and 15 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.